Search - tctmd.com

Displaying 161 - 180 of 653

Sort: Relevancy | Date

Presentation Fellows 2024

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Presenter: Jay S. Giri

April 14, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

Presentation THT 2024

Post PE Syndrome

Presenter: Paul Forfia

March 06, 2024

Presentation THT 2024

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Presenter: Candice Lee

March 06, 2024

Presentation THT 2024

Case Resolution

Presenter: Sareena George

March 06, 2024

Presentation THT 2024

Catheters Are Over-Rated! Heparin as the Primary Option

Presenter: Sanjum S. Sethi

March 06, 2024

Presentation THT 2024

Catheter Directed Lytics as the Primary Option

Presenter: Adnan Khalif

March 06, 2024

Presentation THT 2024

Catheter Thrombectomy as the Primary Option

Presenter: Kenneth Rosenfield

March 06, 2024

Presentation THT 2024

Case Presentation

Presenter: Sareena George

March 06, 2024

Presentation THT 2024

Risk Stratification and Treatment Goals of Acute PE

Presenter: Catalin Toma

March 06, 2024

Presentation THT Abstracts 2024

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Presenter: Daniel Snyder

March 05, 2024

Presentation THT Abstracts 2024

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Presenter: Robert Zilinyi

March 04, 2024

Presentation THT Abstracts 2024

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Presenter: Robert Zilinyi

March 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Conference News ISET 2024

AI Tools to Meet Every Need? The Future of Vascular Medicine

Caitlin E. Cox

February 02, 2024

News Conference News ISET 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

Caitlin E. Cox

January 30, 2024

News Daily News

Outpatient Management of Acute PE Remains Underused

Todd Neale

January 29, 2024

News Conference News ISET 2024

AI Tools Can Flourish in CV Medicine, but Clinical Acumen Remains Key

Caitlin E. Cox

January 23, 2024

News Daily News

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

Todd Neale

January 21, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

Advertisement

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Post PE Syndrome

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Case Resolution

Catheters Are Over-Rated! Heparin as the Primary Option

Catheter Directed Lytics as the Primary Option

Catheter Thrombectomy as the Primary Option

Case Presentation

Risk Stratification and Treatment Goals of Acute PE

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

TCTMD’s Top 10 Most Popular Stories for February 2024

AI Tools to Meet Every Need? The Future of Vascular Medicine

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

Outpatient Management of Acute PE Remains Underused

AI Tools Can Flourish in CV Medicine, but Clinical Acumen Remains Key

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content